Roundtable Discussion: Navigating the Current Anti-VEGF Treatment & Paving the Path for the Future of Retinal Vascular Disease Drug Development for Improved Patient Care
Time: 3:10 pm
day: Conference Day 1
Details:
- Preclinical Models Table: Discovering the latest preclinical models – in vivo, in vitro and ex vivo – being developed and implemented to accurately reflect the retinal vascular environment such as a 3D model of the blood retinal barrier plus expressing key physiological and biological characteristics
- Beyond VEGF Table: Exploring novel target pathways, beyond VEGF, for inhibiting angiogenic factors and regulating various pathways involved in retinal vascular diseases
- Delivery to the Retina: Examining the potential of more durable drug delivery routes to provide less invasive alternatives to intravitreal injections and improve patient compliance
Moderator Feedback & Audience Debate:
Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open up wider audience debate
